Expression of endogenous FGF21 is decreased by Dnmt3a-mediated DNA methylation at the Fgf21 promoter, while exogenous FGF21 can restore Dnmt3a overexpression-induced insulin resistance (55). The gene discussed is FGF21; the disease is Insulin resistance.